Celldex Therapeutics shares owned by Schroder Investment Management Group
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Schroder Investment Management Group
from 13F filings
Historical chart of Schroder Investment Management Group investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Schroder Investment Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Schroder Investment Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.3M | 48k | 26.19 |
| 2025-06-30 | $979k | 48k | 20.35 |
| 2025-03-31 | $959k | 48k | 19.93 |
| 2024-12-31 | $1.2M | 48k | 25.12 |
| 2024-09-30 | $1.6M | 48k | 33.20 |
| 2024-06-30 | $1.8M | 48k | 37.01 |
| 2024-03-31 | $2.0M | 48k | 41.97 |
| 2023-12-31 | $1.9M | 48k | 39.66 |
More positions owned by Schroder Investment Management Group
View all positions for Schroder Investment Management Group